Abstract
The follicular helper T (Tfh) cells help is critical for activation of B cells, antibody class switching, and germinal center (GC) formation. The Tfh cells are characterized by the expression of CXC chemokine receptor 5 (CXCR5), ICOS, programed death 1 (PD-1), B cell lymphoma 6 (BCL-6), and IL-21. They are involved in clearing infections and are adversely linked with autoimmune diseases and also have a role in viral replication as well as clearance. On the one hand, Tfh cells are generated from naive CD4+ T cells with sequential steps involving cytokine signaling (IL-21, IL-6, IL-12, activin A), migration, and positioning in the GC by CXCR5, surface receptors (ICOS/ICOSL, signaling lymphocyte activation molecule-associated protein/signaling lymphocyte activation molecule) as well as transcription factor (BCL-6, c-Maf, and signal transducer and activator of transcription 3) signaling and repressor miR155. On the other hand, Tfh generation is negatively regulated at specific steps of Tfh generation by specific cytokine (IL-2, IL-7), surface receptor (PD-1, CTLA-4), transcription factors B lymphocyte maturation protein 1, signal transducer and activator of transcription 5, T-bet, KLF-2 signaling, and repressor miR 146a. Interestingly, miR-17–92 and FOXO1 act as a positive as well as a negative regulator of Tfh differentiation depending on the time of expression and disease specificity. Tfh cells are also generated from the conversion of other effector T cells as exemplified by Th1 cells converting into Tfh during viral infection. The mechanistic details of effector T cells conversion into Tfh are yet to be clear. To manipulate Tfh cells for therapeutic implication and or for effective vaccination strategies, it is important to know positive and negative regulators of Tfh generation. Hence, in this review, we have highlighted and interlinked molecular signaling from cytokines, surface receptors, transcription factors, ubiquitin ligase, and microRNA as positive and negative regulators for Tfh differentiation.
Introduction
Follicular helper T cell (Tfh), a subset of helper CD4+ T cells, is involved in providing critical help for antibody maturation and germinal center (GC) formation (1). Robust regulation of Tfh cell response and subsequent antibody maturation are critical for infection clearance (2, 3), whereas aberrancy in controlling Tfh immune response is implicated in progression of autoimmune diseases such as systemic lupus erythematosus (SLE), arthritis, and type I/II diabetes (4–10). Moreover, Tfh cells were found to be choice of cells for HIV virus replication and survival (3, 11, 12). Because of association of Tfh cell with pathogenic as well as autoimmune diseases, attempts were made to increase or decrease Tfh cell number in order to reduce disease severity, pathology, and infection. As an example, improvement in beta cell function as a result of reduction in Tfh number was observed upon treatment of rituximab (anti-CD20) in patient with type I diabetes (13). In case of infection, HIV virus drives expansion of Tfh cell and blocking of programed death 1 (PD-1) receptor in HIV-infected humanized mice, inhibited HIV viral growth (14, 15). Thus, these studies prove that Tfh immune response can be regulated positively or negatively, and to better understand Tfh response modulation, it is important to characterize Tfh differentiation and its regulators.
Follicular helper T cells are characterized by expression of CXC chemokine receptor 5 (CXCR5) that is attracted toward CXCL-13 present in the B cell zone enabling these cells to enter interior of B cell follicle (16, 17). These cells are more precisely characterized by co-expression of ICOS (18), PD-1, cytokine IL-21 (19), and transcription factor B cell lymphoma 6 (BCL-6) (20–23) along with CXCR5. Moreover using knockout mice, it has been found that IL-6, IL-21, and BCL-6 are indispensable for Tfh differentiation (24). In contrast, Tfh differentiation in humans requires IL-12 and activin A signaling (25, 26). The CXCR5+ cells representing effector Tfh (27) or memory Tfh cells (1, 28–30) are also found in blood circulation. These circulating Tfh cells are functionally active to help B cells for antibody production (31). The Tfh cells can also be differentiated from other effector T cells (32) as exemplified in sustained viral infection where Th1 cells can be redirected to Tfh (33). Thus, Tfh cells can be generated from either differentiation of naive CD4+ T cells or from already differentiated effector T cells. In contrast, Tfh differentiation is negatively regulated by cytokine (IL-2, IL-7), surface receptor (CTLA-4, PD-1), transcription factors [B lymphocyte maturation protein 1 (Blimp-1), Klf-2], ubiquitin ligase, microRNA (miRNA), and Tfr cells. The mechanistic details for positive and negative regulation of Tfh differentiation are highlighted in this review.
Tfh Differentiation and Inhibition
Positive and negative regulation of Tfh generation is multifactorial, multistep, and spatiotemporal (Figure 1) (24, 34–38). The expression of LEF-1, TCF-1 and later BCL-6 and ICOS on naive CD4+ T cells upon antigen presentation and co-stimulation, marks the early event of Tfh differentiation (39). This early event of Tfh differentiation is inhibited by Il-2, Blimp-1, FOXP1, FOXO1, Cul3, Roquin, and CTLA-4. Signaling from ICOS/ICOSL is involved in down-regulation of Blimp-1, T-bet, and CCR7 and upregulation of Tfh homing marker CXCR5 through regulation of Klf2 (39, 40). In addition, activin A signaling is required for down-regulation of CCR7 and up-regulation of CXCR5 during Tfh differentiation from human naive CD4+ T cell (26). The down-regulation of CCR7 and up-regulation of CXCR5 leads to migration of early Tfh cells from T:B cell border to interior of B cell follicle. This stage of Tfh generation is inhibited by IL-2 and CTLA-4 from early Tfh, Treg, and Tfr (41, 42). Understanding how these early Tfh cells cross the barrier of intrinsic CTLA-4, Treg and Tfr regulation and/or generation of Tfh cells is spatiotemporal is yet to be discovered. Once this barrier is crossed, the late events in GC involve stable interaction of T and B cells through signaling lymphocyte activation molecule-associated protein (SAP)/signaling lymphocyte activation molecule (SLAM) signaling that further allows crosstalk between T and B cells. The SAP/SLAM signaling also regulates ICOS and CD40 expression. At this juncture, ICOS/ICOSL signaling is critical, as blocking ICOS signaling leads to reversion of these cells to other effector T cells by downregulation of CXCR5 and upregulation of CCR7 resulting in migration of these cells off the B cell follicle (39). At this particular point, Tfh differentiation can also be negatively regulated through IL-2, CTLA4 from Tfh or Tfr. Thus, cytokines, transcription factors, surface receptors, ubiquitin ligase, and miRNA act as positive and negative regulators of Tfh differentiation with mechanistic details as follows.
Figure 1
Cytokine as Positive and Negative Regulators of Tfh Differentiation
Cytokine signaling is critical for cell survival, differentiation, proliferation, and also to undergo programed cell death. Along with antigen and costimulatory molecules, cytokine signaling plays a major role in driving naive CD4+ T cells to differentiate into specific effector T cell subsets. In studies with IL-21 and IL-6 knockout mice, it has been found that these cytokines are indispensable for Tfh differentiation. IL-21 cell intrinsically acts on the naive T cells to differentiate into Tfh through Vav1 (43), whereas IL-6 acts both intrinsically and extrinsically to enhance IL-21 production through c-Maf (44). Moreover IL-27, a heterodimeric cytokine is critical for the survival of activated cells as well as for the expression of Tfh marker. IL-27 enhances IL-21 production from naive CD4+ T cells and thereby supports GC formation and B cell functions (45). However in humans, along with IL-21 and IL-6, other cytokines such as IL-12 and TGF-β either solely or conjunctionally are involved in Tfh differentiation (25).
Cytokine interferons are involved in clearance of intracellular infection and seem to have positive roles in Tfh differentiation. The type I IFN-alpha/beta is involved in incomplete Tfh differentiation as they can induce BCL-6, CXCR5, and PD-1 expression through STAT1 signaling without IL-21 production (46). The type II interferon-gamma (IFN-γ) plays a positive role in Tfh differentiation as accumulation of Tfh was observed due to excess IFN-γ as shown in the Sanroque Lupus model (47). The blockade of IFN-γ reduces Tfh cells in Lupus demonstrating that IFN-γ plays an important positive role in Tfh generation. Mechanistically, excess IFN-γ signaling leads to increased BCL-6 expression (Figure 2) (47). In contrast, in late stage of Th1 differentiation, BCL-6 binds with the Ifng locus and represses over-production of IFN-γ (48). Therefore, it seems that BCL-6 and IFN-γ regulate each other by negative feedback mechanism.
Figure 2
The cytokines IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 signal through a common gamma chain receptor but have differential effect on T cell survival, proliferation, maintenance, and differentiation. Mechanistically, IL-2 positively regulates Th1 and Th2 differentiation through IL-12Rβ2 and IL-4ra expression, respectively, while it negatively regulates Th17 and Tfh differentiation by inhibiting the expression of IL-6 receptor α-chain (IL-6ra) (49). During influenza virus infection, impairment in GC and influenza-specific memory B cell formation was observed upon IL-2 administration. And this impairment was due to the suppression of Tfh cell differentiation by IL-2 (41). In another study in influenza infection, Treg cell decreased the availability of IL-2 to naive CD4+ T cells and thereby promoted Tfh differentiation and enhanced GC formation and antibody response. Moreover, depletion of Treg cells during the influenza infection leads to severe reduction in Tfh cells due to excess availability of IL-2 (50). A recent study depicts that IL-2 through activation of Akt and mTORc1 kinase drives cells toward Th1 rather than Tfh differentiation (51). The cytokine IL-7 acts a negative regulator of Tfh differentiation by activating signal transducer and activator of transcription 5 (STAT5) and thereby repressing Bcl-6 and Cxcr5 (52). Therefore, IL-21, IL-6, IL-27, IL-12, IFN-γ, and type I IFNs alpha/beta are positive regulators of Tfh differentiation, while IL-2 and IL-7 act as negative regulators of Tfh differentiation.
Surface Receptors – Positive Regulator
CD28/B7 (CD-80 or CD86) Pathway
For naïve CD4+ T cell to differentiate into effector T cell, it requires antigenic peptide presentation through MCH-II and CD28 costimulation by antigen-presenting cells such as dendritic cells, macrophage, or B cells along with lineage driving cytokines. Signaling from CD28 by binding with its ligand CD80 (B7-1) or CD86 (B7-2) is critical for antibody class switching and GC formation (53, 54). Studies suggest that B7-1 and B7-2 have overlapping function as evidence from unaltered antibody response in mice lacks either of the molecules (53, 55). However, during vaccinia virus infection, expression of B7-2, but not B7-1, is critical for the generation of Tfh cells and thus plasma cell generation and virus specific antibodies (56). CD28 signaling positively regulates early stage of Tfh differentiation (expression of ICOS and BCL-6), and its signaling is also important at late stage of Tfh differentiation as exemplified in blocking B7 ligand during ongoing infection impaired Tfh response (39, 57, 58). Sustained signaling from CD28 is critical for Tfh survival as evidence from apoptosis of Tfh cells during influenza viral or Citrobacter rodentium infection into a mice strain that after initial priming selectively lose CD28 expression on CD4 T cells (58). Although CD28 signaling plays critical role in Tfh differentiation and maintenance, its downstream PI3k activation is dispensable for its generation and during infection with Salmonella in Roquin mutant mice, the generation Tfh does not depend on CD28 signaling (59). Thus, requirement of CD28 downstream signaling for Tfh generation may be infection specific, and still there is scope to determine unknown CD28 downstream signaling molecules.
CXC Chemokine Receptor 5
The presence of CXC chemokine receptor 5 (CXCR5), a hallmark Tfh cell surface marker, differentiates these cells from other T cell lineages (60, 61). Migration of T cells to the B cell zone is mediated by CXCR5, which is attracted toward CXCL13 ligand of B cell follicle (62), thereby promoting T:B cell contact. Although T cells are found in B cell follicle of immunized mice (selectively null for CXCR5 T cells), these mice were still found to have low GC number and decreased humoral immune response (63). Thus, CXCR5 is important for T cell positioning to follicular GC. However, it is also important that these cells should express low CCR7 expression as its signaling promotes retention of T cells to the T cell area of GC (64, 65). Signaling through activin A plays critical role in downregulation of CCR7 and upregulation of CXCR5 expression (26). Moreover, Tfh cells express high NFAT2 transcription factor that is involved in CXCR5 expression (66). Reduced CXCR5 expression was observed in NFAT2, NFAT1/2-deficient mice-infected LCMV Armstrong strain, indicating that nuclear factor of activated T cell (NFAT) plays critical role in Tfh differentiation by regulating CXCR5 expression (67).
ICOS/ICOSL Signaling
Upon antigen challenge and CD28 costimulation, ICOS is expressed on all effector T cells, and its signaling through ICOS-ICOSL is critical for Tfh generation and GC formation (18, 68). In patients with ICOS deficiency, the GC is severely damaged, and reduction in CXCR5+ CD45RO+ memory cells validates the importance of the ICOS in Tfh differentiation (69). During an acute viral infection, T cells that intermediately express IL-2 receptor α induces the expression of BCL-6 and CXCR5 through ICOS signaling leading to Tfh differentiation by 72 h of antigen challenge, without the help of B cell, whereas T cells expressing higher IL-2 receptor α induces Blimp-1 expression driving the cells toward other effector T cells subsets (70). After 72 h, the differentiated Tfh cells die due to the absence of ICOSL signal from B cells. Thus, sequential ICOS signaling is important for Tfh generation as well as maintenance.
Although PI3k is activated by signaling through T cell receptor (TCR), CD28, the ICOS-driven PI3k activation, is critical for Tfh cell as suggested by impaired Tfh generation in mice selectively defective in ICOS downstream signaling of the PI3k activation (71). Moreover, conditional deletion of catalytic subunit P110delta of PI3k also validate that the ICOS downstream PI3k pathway is important for Tfh generation (72). Other than known PI3K binding motif Tyr-x-x-Met (YxxM, where ‘x’ indicates any amino acid) of ICOS, Pedros et al. using SILAC (stable isotope labeling) approach showed that ICOS cytoplasmic tail has other two conserved motifs, one Proximal SSSVHDPNGE (IProx) and second AVNTAKK motif. Retroviral transduction of CD4+ T cells (TCR transgenic for LCMV peptide gp 61–80) with ICOS mutant in PI3k-binding site of IProx motif and adoptive transfer into ICOS−/− mice and then LCMV infection fail to generate Tfh cells illustrating that IProx plays a critical positive role in Tfh differentiation (73). Importantly, IProx motif has homology with the conserved sequences with TRAF2 and TRAF3. Furthermore, IProx motif is involved in recruitment of serine threonine kinase TBK-1, and depletion of TBK-1 is associated with impaired Tfh generation. Strong TCR and ICOS signaling is needed for activation of TBK-1 pathway. Moreover, ICOS signaling also regulates IL-21 production through c-Maf, which in turn regulates Tfh differentiation (74). Recently, ICOS signaling has been associated with Tfh phenotype maintenance by FOXO1-mediated downregulation of transcription factor Kruppel-like factor 2 (KLF2) (39). KLF2 negatively regulates Tfh differentiation by directly binding to Cxcr5, Cccr7, Psgl-1, and S1pr1 receptors, which leads to suppression of CXCR5 expression. In addition to Klf2, FOXO1 is also repressed by ICOS-induced mTORc2, thereby promoting Tfh differentiation (75). Although FOXO1 degradation is necessary for early-stage Tfh differentiation, however during late stage, it is required for transcription of several genes that help in Tfh differentiation (76).
Signaling Lymphocyte Activation Molecule-Associated Protein
The adaptor molecule SAP is very critical for the generation of antigen-specific long-lived plasma and memory B cells (77) by stabilizing T:B cell interaction (78). Two-photon imaging (79) showed that SAP deficiency selectively impairs T:B cell interaction rendering impaired T cell migration and retention in GC. SLAM/SAP signaling not only regulates stable T:B cell interaction but also exhibits a regulatory role in the expression of ICOS and CD40L (80). Thus, SLAM/SAP signaling positively regulates Tfh differentiation by stabilizing T and B cell interaction as well as the expression of ICOS and CD40L.
OX40/OX40L
Signaling through costimulatory molecule OX40 (CD138) and its ligand OX40L (CD252) is critical for T cell survival, proliferation, and differentiation (81–83). Classically, OX40 expression on T cells is considered to be transient with the exception during chronic LCMV clone 13 and Plasmodium infection wherein it is constantly expressed (84, 85). Enhancing signaling through OX40 is critical to control rodent malaria parasite infection by Tfh generation and GC response. Increasing OX40 signaling with OX40 agonistic antibody along with blocking PD-1 signaling leads to loss of Tfh generation by Blimp-1 expression and excessive IFN-γ production and thus impaired malaria parasite clearance (85). Therefore, it seems that the crosstalk between costimulatory and co-inhibitory receptor signaling is important for Tfh generation. In contrast, enhancing OX40 signaling during LCMV Cl 13 infection and initial priming of Listeria monocytogenes leads to inhibition of Tfh differentiation by increasing transcriptional repressor Blimp-1 (86, 87). Whereas following L. monocytogenes infection, enhancing OX40 signaling does not alter the Tfh number stating that the time of OX40 stimulation is an important factor for regulating Tfh differentiation. Moreover, infection with L. monocytogenes in mice deficient in OX40 and CD30 showed normal Tfh generation (86). However, OX40-deficient mice with LCMV Cl 13 infection showed impaired generation of Tfh cell, GC, and plasma cells (84). Thus, it seems that infection-specific tight regulation of OX40 signal is required for Tfh cell generation. Further, despite low memory CD4 T cell and low circulating memory B cells, intact antibody response to vaccination was observed in patient with OX40 deficiency (88). Aberrantly increased Tfh response leading to SLE is contributed by signaling through OX40 ligand (OX40L)–OX40 axis by augmentation of TCR signal via PI3K–Akt pathway (89). Thus, robust regulation of OX40/OX40L signaling is associated with positive and negative regulation of Tfh differentiation.
GITRL/GITR
During chronic LCMV infection and in collagen-induced arthritis (CIA) mice, the expression of glucocorticoid-induced TNF receptor family-related protein (GITR) was elevated on Tfh cells than non-Tfh cells (90, 91). Impaired Tfh generation and loss in control of chronic LCMV infection was observed in GITR−/− mice. Moreover, administration of GITR-Fc protein greatly reduced CIA and joint damage by inhibiting Tfh generation and thereby autoantibody production (90). Mechanistically, GITR cell intrinsically expands Tfh number, thereby promoting antibody production to control chronic LCMV Cl13 infection (91). Thus, GITR signaling positively regulates Tfh generation.
Surface Receptors – Negative Regulator
Programed Death 1
Programed death 1, a surface molecule expressed on exhausted T cells, is also expressed by Tfh cells. PD-1/PD-L1 and PDL-2 signaling is associated with the dephosphorylation of molecules downstream of TCR signaling. Mechanistically, PD-1 engagement inhibits ICOS signaling thereby regulating Tfh generation (92). However, IL-2 through STAT5 rescues inhibition of ICOS signaling by PD-1, and additionally, IL-2 itself through STAT5 negatively regulates Tfh differentiation. Therefore, it seems that many positive and negative regulatory pathways of Tfh differentiation are interlinked. The Tfr cells also express PD-1, regulate Tfh cells, and hence humoral immune response (93).
Cytotoxic T Lymphocyte Antigen 4
The cytotoxic T lymphocyte antigen 4 (CTLA-4), a regulatory T cell marker involved in regulation of effector T cells, was recently shown to be expressed by Tfh (42) and Tfr (42, 94) cells and negatively regulates Tfh differentiation. Downregulation or loss of CTLA-4 in Tfh cells and Treg cells resulted in augmented B cell response, while loss of CTLA-4 in Tfr was not able to augment B cell response. Mechanistically, Tfr and Treg control Tfh and humoral immunity by downregulating costimulatory molecule B7-1 and B7-2 through CTLA-4 (Figure 3) (42, 94). In contrast to this, earlier studies have shown that CTLA-4 activates ubiquitin ligase Itch resulting in inhibition of T cell activity (95), whereas recent studies have shown Itch has a positive regulator of Tfh differentiation (96). However, it is possible that CTLA-4 function may be controversial and milieu dependent or it may have new Tfh regulatory signaling pathways which are yet to be identified.
Figure 3
Transcription Factors – As Positive and Negative Regulators of Tfh Differentiation
Signal Transducer and Activator of Transcription 3
Signal transducer and activator of transcription 3 (STAT3) plays a critical role as a positive regulator in Tfh differentiation (97). Mice with T cell-specific STAT3 deficiency showed reduced B cell response (98). Moreover, studies in human patients with STAT3 deficiency were reported with reduced circulating Tfh cells, defective IL-21 expression, and B helper activity supporting that STAT3 is a critical positive regulator of Tfh differentiation (40). Mechanistically, IL-6 enhances Tfh generation through expression of STAT3, which in turn regulates IL-21 production. In CD8 cells, IL-6-induced NFAT2/STAT3 was found to interact with Pdcd1 gene promoter thereby regulating PD-1 (36). Thus, it is possible that IL-6-induced NFAT2/STAT3 might also be involved in the expression of PD-1 of Tfh cells.
B Cell Lymphoma 6
Follicular helper T cells cannot be generated in the absence of the transcriptional repressor BCL-6, implicating its importance in Tfh differentiation and persistence (99, 100). Ectopic BCL-6 expression leads to induction of CXCR5, ICOS, and PD-1 on CD4+ T cells (37, 101). BCL-6 promotes Tfh differentiation by inhibiting other T cell subset differentiation in a DNA binding-dependent manner. BCL-6 also regulates Th1 and Th17 cells by binding to T-bet and RORγt promoter thereby regulating IFN-γ and IL-17 production (101). Furthermore, BCL-6 directly binds with the AP-1 and blocks or subverts downstream TCR signaling of AP-1 and helps in Tfh generation (21). Yu et al. showed that the miRNAs, including miR-17–92 involved in CXCR5 repression, are repressed by BCL-6, driving the cells toward Tfh differentiation (101). BCL-6 has also been implicated in downregulation of P-selectin glycoprotein ligand 1 (PSGL1) simultaneously upregulating CXCR5 and PD-1 (102). Mechanistically, out of bric-a-brac, tramtrack, broad-complex (BTB) domain, a middle domain (also known as RDII), and a zinc finger domain of BCL-6, the BTB domain through interacting with BCOR (103), and middle domain RDII by associating with metastasis-associated protein 3 (MTA3) play critical role in Tfh differentiation (104, 105). Further acetylation of RDII domain at K379 prevents binding of MTA3, thereby inhibiting Tfh differentiation.
c-Maf
Cytokine IL-6 (44), IL-27 (106), and ICOS (74) induced c-Maf, which regulates IL-21 production, which in turn regulates Tfh generation. BCL-6 controls expression of most of the genes related to Tfh differentiation but does not have any role in IL-21 expression. Over-expression of c-Maf induces IL-21 production without signaling from IL-6/IL-4/STAT6 signaling (44). Mechanistically, c-Maf regulates IL-21 production through MARE site binding to the activated IL-21p and the CNS-2 enhancer (44). c-Maf induction is also involved in the expression of CXCR5 (107).
Aschaete Scute Homolog 2
Aschaete scute homolog 2 (Ascl2), a basic helix-loop-helix (bHLH) transcription factor, is specifically upregulated in Tfh cells. It positively regulates Tfh generation as blockade of Ascl2 signaling with Id3 leads to impaired Tfh generation (108). Ascl2 is involved in upregulation of the CXCR5 and downregulation of CCR7, thus helping in migration of these cells to the GC (108).
Interferon Regulatory Factor 4
Interferon regulatory factor 4 (IRF4) controls expression of BCL-6, as Irf4−/− CD4+ T cells failed to express BCL-6, thus regulating the Tfh generation (109).
Nuclear Factor of Activated T Cell Proteins
The transcription factor NFAT consists of five members, namely, NFAT1 (NFATp or NFATc2), NFAT2 (NFATc or NFATc1), NFAT3 (NFATc4), NFAT4 (NFATx or NFATc3), and NFAT5. Signaling through Ca2+ regulates NFAT1, NFAT2, NFAT3, and NFAT4. The Ca2+ signaling-regulated NFAT1, NFAT2, and NFAT4 is critical for T cell activation, differentiation, and maintenance of tolerance (110–112). Recently, it has been shown that Tfh cells express high NFAT2 transcription factor that is involved in CXCR5 expression. Reduced expression of Tfh markers CXCR5, ICOS, and PD-1 was observed in NFAT2, NFAT1, 2-deficient mice infected with LCMV Armstrong strain, which illustrates important positive role for NFAT1 and NFAT2 in Tfh differentiation (67). In contrast, unexpectedly, augmented GC reaction was observed upon immunization in mice deficient in NFAT2. However, in these NFAT2-deficient mice, only Tfr population was hampered, indicating that NFAT2 intrinsically downregulates CXCR5 in Tfr than Tfh (66).
Signal Transducer and Activator of Transcription 5
During T cell activation, continuous STAT5 signaling inhibits Tfh generation by regulating expression of CXCR5, c-Maf (113), and BCL-6 (113, 114). Therefore, in vivo inhibition of STAT5 signaling leads to enhanced Tfh cell and GC formation. In the absence of Blimp-1, STAT 5 failed to inhibit Tfh cell formation, whereas over-expression of Blimp-1 in STAT5-deficient T cells resulted in Tfh differentiation. Thus, IL-2/STAT5 axis negatively regulates Tfh differentiation by regulating Blimp-1 (113).
B Lymphocyte Maturation Protein 1
B lymphocyte maturation protein 1, a transcriptional repressor, plays a critical role in the regulation of terminal B (115) as well as T cell differentiation, maturation, survival, and homeostasis (116, 117). It negatively regulates Tfh differentiation by opposing the action of BCL-6 (100) by binding to multiple loci of Bcl-6 genes (118). Blimp-1 also inhibits PD-1 expression by directly repressing NFAT2 (a positive regulator of PD-1), or by binding to PD-1 locus changing the chromatin structure, thereby resulting in the dissociation of NFAT2 from its site (78). Thus, Blimp-1 negatively regulates Tfh differentiation by downregulating BCL-6 and PD-1.
T-Bet
The master transcription factor T-bet and BCL-6 for Th1 and Tfh cells, respectively, have been shown to be co-expressed during early and late stages of differentiation and regulate each other to drive the cells either toward Th1 or Tfh type (119). In the early stages of Th1 cell differentiation, IL-12 priming through STAT4 induces IL-21 and BCL-6, but during late phase of differentiation, STAT4-induced T-bet represses BCL-6 leading naive CD4+ T cell to differentiate into Th1. Recent finding has shown that during late event of Tfh cell differentiation, low expression of KLF-2 at early stages leads to BCL-6 expression and high expression of KLF-2 during later phase results in downregulation of BCL-6 by upregulating BCL-6 antagonistic Blimp-1 and high expression of T-bet (40). Thus, KLF2 may regulate T-bet and thereby negatively regulate Tfh differentiation, but still our knowledge is unclear for molecules that are involved during late event of Th1 differentiation that negatively regulates Tfh differentiating molecules.
E Protein and Its Natural Repressors Id2 and Id3
E protein and its natural repressors, the inhibitor of DNA-binding protein (Id1–Id4), play a critical role in Tfh differentiation. The generation of Tfh cells was increased upon depletion of Id2 via RNA-mediated interference. Moreover, over-expression of Id3 inhibits Tfh generation during LCMV infection or following immunization with protein (120). Ectopic expression of E protein E47 enhanced CXCR5 expression, while Id2 inhibits CXCR5 expression. Chromatin immunoprecipitation (ChIP) followed by deep sequencing has revealed that Bcl-6 binds with Id2 locus repressing Id2 expression thereby positively regulating Tfh differentiation (120).
Forkhead/Winged Helix Transcription Factor
FOXP1
FOXP1 intrinsically negatively regulates naive CD4+ T cell differentiation into effector function by antagonizing FOXO1 and also through inhibition of MEK and ERK signaling (121). FOXP1-deficient naive CD4+ T cells upon TCR stimulation differentiate preferentially into Tfh type, indicating its critical negative role in Tfh differentiation (122). FOXP1, through its isoforms FOXP1A and FOXP1D, directly suppresses IL-21 production, ICOS expression, and ICOS downstream signaling (122).
FOXO1
FOXO1, a member of forkhead box transcription factor family, is involved in T cell homeostasis and nutrients and growth factor adaptation. It controls lymphocyte trafficking by regulating the adhesion molecule L-selectin, chemokine receptor CCR7, and transcription factor KLF2 (123–125). FOXO1 deficiency led to enhanced expression of KLF 2 that negatively regulates Tfh generation. In contrast, viral infection studies show that degradation of FOXO1 by ubiquitin E3 ligase Itch enhances Tfh differentiation (96). Moreover, a recent study showed that during late stage of Tfh differentiation, FOXO1 can positively regulate Tfh differentiation, although its regulatory molecules are yet to ascertain (76). Therefore, FOXO1 regulates Tfh differentiation positively as well as negatively that may be time dependent involving unknown molecules.
Kruppel-Like Factor 2, Also Known as Lung Kruppel-Like Factor
Kruppel-like factor 2, member of zinc finger transcription factor, is involved in T cell homeostasis, trafficking, and survival, and KLF2-deficient mice showed reduction in peripheral T cells (126–128). Lee et al. showed that the KLF2 deficiency or low levels of KLF2 have been shown to be associated with enhanced Tfh cell differentiation. Moreover, over-expression of KLF2 leads to blocking or reduction of Tfh cell differentiation and thereby resulting in reduced GC formation (40). Mechanistically, KLF2 negatively regulates Tfh differentiation by directly binding to Cxcr5, Ccr7, Psgl-1, and S1pr1 and thus negatively regulating homing receptor (39, 40). The other mechanism by which KLF2 regulates Tfh differentiation is through the induction of Blimp-1, T-bet, and GATA3 expression (40).
LEF-1 and TCF-1
The transcription factors LEF-1 and TCF-1 act as a positive regulator of Tfh differentiation and expressed before the expression of Tfh marker CXCR5. During early stage of viral infection, virus-specific Tfh cells reciprocally express TCF-1 and Blimp-1 (129). The TCF-1 deficiency led to poor differentiation of Tfh cells and their maintenance. Mechanistically, TCF-1 regulates Tfh differentiation by directly binding to the Bcl6 promoter and prdm 5′ regulatory region enhancing BCL-6 and repression of Blimp-1 protein (130). Moreover, LEF-1, by enhancing IL-6 receptor and ICOS expression, promotes Tfh differentiation (131).
Ubiquitin E3 Ligase
Ubiquitin E3 Ligase Itch as Positive Regulator of Tfh Differentiation
Recent studies have shown that during acute viral infection, ubiquitin ligase Itch plays an important role in Tfh differentiation, GC formation, and humoral immune response (96). The action of Itch was found to be intrinsic and upstream of BCL-6 as forced BCL-6 expression in Itch−/− mice restored Tfh differentiation. Mechanistically, Itch activates FOXO1 ubiquitination and degradation, thereby helping Tfh differentiation. The deletion of FOXO1 in Itch−/− mice rectifies the Tfh differentiation validating the fact that Itch mediated degradation is crucial for Tfh differentiation (96).
Ubiquitin E3 Ligase Cullin3 as Negative Regulator of Tfh Differentiation
The E3 ligase Cullin3 (Cul3) binds to BCL-6 and negatively regulates Tfh differentiation by ubiquitination of histone proteins. Knocking down E3 ligase Cul3 from CD4 cells resulted in over-expression of basic leucin zipper transcription factor, ATF-like (Baft), a target of BCL-6 leading to exaggerated or enhanced Tfh generation during antigen challenge (132).
Ubiquitin E3 Ligase ROQUIN as Regulator of Tfh Differentiation
Roquin 1 (Rc3h1) and Roquin 2 (Rc3h2) are paralogous proteins made up of really interesting new gene (RING) finger, ROQ domain, and zinc finger domain and regulates Tfh differentiation at posttranscriptional level. In Roquinsan mice, substitution of M199R within ROQ domain of Roquin 1 leads to enhanced expression of ICOS, thereby promoting aberrant Tfh generation causing lupus like autoimmunity (133). Roquin 1 mechanistically regulates Tfh differentiation by repressing mRNA of ICOS and Ox40 expression (134, 135). Unlike Roquinsan mice, Roquin null mice do not show increase in the ICOS expression but fail to generate aberrant Tfh cells, suggesting that there is involvement of other compensatory regulatory molecule (136). Roquin 2 negatively regulates Tfh differentiation in the absence of Roquin 1 (134, 135). In contrast, hampered antigen-specific Tfh response was observed in mice with T cells specific deletion of Roquin RING domain depicting Roquin RING domain positively regulates Tfh differentiation. Mechanistically, Roquin directly binds with AMPKα subunit and thus represses adenosine monophosphate-activated protein kinase (AMPK) activity (137).
microRNA
microRNA regulates gene expression at posttranscriptional level and thereby is crucially involved in regulation proliferation, differentiation, and programed cell death. Studies depict critical positive and negative roles of microRNA in the Tfh differentiation. In 2009, Yu et al. showed that the microRNAs, including miR-17–92 involved in CXCR5 repression, are repressed by BCL-6-driving cells toward Tfh differentiation (101), while during viral infection, over-expression of miR-17–92 is importantly involved in Tfh differentiation (138, 139). Thus, miR-17–92 may regulate Tfh differentiation positively or negatively. During chronic low-grade inflammation, miR-155 is involved in progression of inflammatory disease by increasing the number of Tfh cell number. On the other hand, miR-146a counterregulates microRNA-155 and reduces the number of Tfh cells (140). Mechanistically, miR-146a regulates ICOS/ICOSL signaling by repressing messenger RNA involved in ICOS expression (141). Thus, micorRNA regulates Tfh differentiation positively as well as negatively.
Conclusion
Follicular helper T cells are known for their critical help in GC formation, and B cell maturation for infection clearance is also implicated in the autoimmune diseases and virus replication. In order to clear infection and to prevent immunopathology, precise manipulation of Tfh regulatory molecular network is needed to generate adequate Tfh cell number. Adequate Tfh cell number may be generated by manipulating Tfh regulatory molecules such as cytokines, transcription factors, surface receptors, ubiquitin ligase, and miRNAs. Further research is needed to ascertain regulatory molecules either positive or negative for generation of Tfh from effector T cells. The generation of adequate Tfh number and its critical help for optimum GC formation and B cell maturation will be helpful for effective vaccination strategy.
Statements
Author contributions
GJ and SD discussed and revived the literature; GJ drafted the manuscript. GJ, SD, and SM prepared illustrations, discussed, and revived the manuscript. All the authors critically revised the manuscript for intellectual content and approved it for publication.
Funding
This work was supported in part by institutional core fund (Institute of Life Sciences) and from Department of Biotechnology, Govt. of India (Grant number-BT/PR11259/BRB/10/646/2008 and BT/PR14425/BRB/10/839/2010). GJ is supported by Senior Research fellowship of Council of Scientific and Industrial Research (CSIR).
Conflict of interest
The authors declare that the research conducted has no commercial or financial involvement that could be considered as potential conflict of interest.
References
1
HeJTsaiLMLeongYAHuXMaCSChevalierNet alCirculating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity (2013) 39:770–81.10.1016/j.immuni.2013.09.007
2
ElsaesserHSauerKBrooksDG. IL-21 is required to control chronic viral infection. Science (2009) 324:1569–72.10.1126/science.1174182
3
CookKDShpargelKBStarmerJWhitfield-LarryFConleyBAllardDEet alT follicular helper cell-dependent clearance of a persistent virus infection requires T cell expression of the histone demethylase UTX. Immunity (2015) 43:703–14.10.1016/j.immuni.2015.09.002
4
ChoiJYHoJHPasotoSGBuninVKimSTCarrascoSet alCirculating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol (2015) 67:988–99.10.1002/art.39020
5
MaJZhuCMaBTianJBaidooSEMaoCet alIncreased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol (2012) 2012:827480.10.1155/2012/827480
6
ZhangXLindwallEGauthierCLymanJSpencerNAlarakhiaAet alCirculating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production. Lupus (2015) 24(9):909–17.10.1177/0961203314567750
7
ChevalierNMaciaLTanJKMasonLJRobertRThorburnANet alThe role of T follicular helper cell molecules, and environmental influences, for autoantibody production and progression to inflammatory arthritis. Arthritis Rheumatol (2016) 68(4):1026–38.10.1002/art.39481
8
FerreiraRCSimonsHZThompsonWSCutlerAJDopicoXCSmythDJet alIL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia (2015) 58:781–90.10.1007/s00125-015-3509-8
9
WangQZhaiXChenXLuJZhangYHuangQ. Dysregulation of circulating CD4+CXCR5+ T cells in type 2 diabetes mellitus. APMIS (2014) 123:146–51.10.1111/apm.12330
10
KenefeckRWangCJKapadiTWardzinskiLAttridgeKCloughLEet alFollicular helper T cell signature in type 1 diabetes. J Clin Invest (2014) 125:292–303.10.1172/JCI76238
11
PerreauMSavoyeALDe CrignisECorpatauxJMCubasRHaddadEKet alFollicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med (2012) 210:143–56.10.1084/jem.20121932
12
PetrovasCKoupRA. T follicular helper cells and HIV/SIV-specific antibody responses. Curr Opin HIV AIDS (2014) 9:235–41.10.1097/COH.0000000000000053
13
XuXShiYCaiYZhangQYangFChenHet alInhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes. PLoS One (2013) 8:e79858.10.1371/journal.pone.0079858
14
PalmerBENeffCPLecureuxJEhlerADsouzaMRemling-MulderLet alIn vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized mice. J Immunol (2013) 190:211–9.10.4049/jimmunol.1201108
15
LindqvistMvan LunzenJSoghoianDZKuhlBDRanasingheSKraniasGet alExpansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest (2012) 122:3271–80.10.1172/JCI64314
16
ChenXMaWZhangTWuLQiH. Phenotypic Tfh development promoted by CXCR5-controlled re-localization and IL-6 from radiation-resistant cells. Protein Cell (2015) 6(11):825–32.10.1007/s13238-015-0210-0
17
MoserB. CXCR5, the defining marker for follicular B helper T (Tfh) cells. Front Immunol (2015) 6:296.10.3389/fimmu.2015.00296
18
MarafiotiTPatersonJCBallabioEChottANatkunamYRodriguez-JustoMet alThe inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. Haematologica (2010) 95:432–9.10.3324/haematol.2009.010991
19
McGuireHMVogelzangAWarrenJLoetschCNatividadKDChanTDet alIL-21 and IL-4 collaborate to shape T-dependent antibody responses. J Immunol (2015) 195(11):5123–35.10.4049/jimmunol.1501463
20
ChoiYSYangJAYusufIJohnstonRJGreenbaumJPetersBet alBcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory. J Immunol (2013) 190:4014–26.10.4049/jimmunol.1202963
21
HatziKNanceJPKroenkeMABothwellMHaddadEKMelnickAet alBCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms. J Exp Med (2015) 212:539–53.10.1084/jem.20141380
22
LeeSKRigbyRJZotosDTsaiLMKawamotoSMarshallJLet alB cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J Exp Med (2011) 208:1377–88.10.1084/jem.20102065
23
LiuXYanXZhongBNurievaRIWangAWangXet alBcl6 expression specifies the T follicular helper cell program in vivo. J Exp Med (2012) 209:S1841–1824.10.1084/jem.20120219
24
NurievaRIChungYHwangDYangXOKangHSMaLet alGeneration of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity (2008) 29:138–49.10.1016/j.immuni.2008.05.009
25
SchmittNMoritaRBourderyLBentebibelSEZurawskiSMBanchereauJet alHuman dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity (2009) 31:158–69.10.1016/j.immuni.2009.04.016
26
LocciMWuJEArumemiFMikulskiZDahlbergCMillerATet alActivin A programs the differentiation of human TFH cells. Nat Immunol (2016) 17:976–84.10.1038/ni.3494
27
MoritaRSchmittNBentebibelSERanganathanRBourderyLZurawskiGet alHuman blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity (2011) 34:108–21.10.1016/j.immuni.2010.12.012
28
SagePTAlvarezDGodecJvon AndrianUHSharpeAH. Circulating T follicular regulatory and helper cells have memory-like properties. J Clin Invest (2014) 124:5191–204.10.1172/JCI76861
29
ChevalierNJarrossayDHoEAveryDTMaCSYuDet alCXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. J Immunol (2011) 186:5556–68.10.4049/jimmunol.1002828
30
HaleJSAhmedR. Memory T follicular helper CD4 T cells. Front Immunol (2015) 6:16.10.3389/fimmu.2015.00016
31
BentebibelSESchmittNBanchereauJUenoH. Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers. Proc Natl Acad Sci U S A (2011) 108:E488–97.10.1073/pnas.1100898108
32
LintermanMAListonAVinuesaCG. T-follicular helper cell differentiation and the co-option of this pathway by non-helper cells. Immunol Rev (2012) 247:143–59.10.1111/j.1600-065X.2012.01121.x
33
FaheyLMWilsonEBElsaesserHFistonichCDMcGavernDBBrooksDG. Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J Exp Med (2011) 208:987–99.10.1084/jem.20101773
34
DeenickEKChanAMaCSGattoDSchwartzbergPLBrinkRet alFollicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling. Immunity (2010) 33:241–53.10.1016/j.immuni.2010.07.015
35
FazilleauNMcHeyzer-WilliamsLJRosenHMcHeyzer-WilliamsMG. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol (2009) 10:375–84.10.1038/ni.1704
36
AustinJWLuPMajumderPAhmedRBossJM. STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells. J Immunol (2014) 192:4876–86.10.4049/jimmunol.1302750
37
NurievaRIChungYMartinezGJYangXOTanakaSMatskevitchTDet alBcl6 mediates the development of T follicular helper cells. Science (2009) 325:1001–5.10.1126/science.1176676
38
BaumjohannDPreiteSReboldiARonchiFAnselKMLanzavecchiaAet alPersistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity (2013) 38:596–605.10.1016/j.immuni.2012.11.020
39
WeberJPFuhrmannFFeistRKLahmannAAl BazMSGentzLJet alICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2. J Exp Med (2015) 212:217–33.10.1084/jem.20141432
40
LeeJYSkonCNLeeYJOhSTaylorJJMalhotraDet alThe transcription factor KLF2 restrains CD4(+) T follicular helper cell differentiation. Immunity (2015) 42:252–64.10.1016/j.immuni.2015.01.013
41
Ballesteros-TatoALeonBGrafBAMoquinAAdamsPSLundFEet alInterleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity (2012) 36:847–56.10.1016/j.immuni.2012.02.012
42
SagePTPatersonAMLovitchSBSharpeAH. The coinhibitory receptor ctla-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells. Immunity (2014) 41:1026–39.10.1016/j.immuni.2014.12.005
43
VogelzangAMcGuireHMYuDSprentJMackayCRKingC. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity (2008) 29:127–37.10.1016/j.immuni.2008.06.001
44
HiramatsuYSutoAKashiwakumaDKanariHKagamiSIkedaKet alc-Maf activates the promoter and enhancer of the IL-21 gene, and TGF-beta inhibits c-Maf-induced IL-21 production in CD4+ T cells. J Leukoc Biol (2010) 87:703–12.10.1189/jlb.0909639
45
BattenMRamamoorthiNKljavinNMMaCSCoxJHDenglerHSet alIL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J Exp Med (2010) 207:2895–906.10.1084/jem.20100064
46
NakayamadaSPoholekACLuKTTakahashiHKatoMIwataSet alType I IFN induces binding of STAT1 to Bcl6: divergent roles of STAT family transcription factors in the T follicular helper cell genetic program. J Immunol (2014) 192:2156–66.10.4049/jimmunol.1300675
47
LeeSKSilvaDGMartinJLPratamaAHuXChangPPet alInterferon-gamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity (2012) 37:880–92.10.1016/j.immuni.2012.10.010
48
OestreichKJHuangACWeinmannAS. The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns. J Exp Med (2011) 208:1001–13.10.1084/jem.20102144
49
LiaoWLinJXWangLLiPLeonardWJ. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol (2011) 12:551–9.10.1038/ni.2030
50
LeonBBradleyJELundFERandallTDBallesteros-TatoA. FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability. Nat Commun (2014) 5:3495.10.1038/ncomms4495
51
RayJPStaronMMShyerJAHoPCMarshallHDGraySMet alThe interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells. Immunity (2015) 43:690–702.10.1016/j.immuni.2015.08.017
52
McDonaldPWReadKABakerCEAndersonAEPowellMDBallesteros-TatoAet alIL-7 signalling represses Bcl-6 and the TFH gene program. Nat Commun (2016) 7:10285.10.1038/ncomms10285
53
BorrielloFSethnaMPBoydSDSchweitzerANTivolEAJacobyDet alB7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity (1997) 6:303–13.10.1016/S1074-7613(00)80333-7
54
FergusonSEHanSKelsoeGThompsonCB. CD28 is required for germinal center formation. J Immunol (1996) 156:4576–81.
55
McAdamAJFarkashEAGewurzBESharpeAH. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J Virol (2000) 74:203–8.10.1128/JVI.74.1.203-208.2000
56
Salek-ArdakaniSChoiYSRafii-El-Idrissi BenhniaMFlynnRArensRShoenbergerSet alB cell-specific expression of B7-2 is required for follicular Th cell function in response to vaccinia virus. J Immunol (2011) 186:5294–303.10.4049/jimmunol.1100406
57
WangCJHeutsFOvcinnikovsVWardzinskiLBowersCSchmidtEMet alCTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement. Proc Natl Acad Sci U S A (2014) 112:524–9.10.1073/pnas.1414576112
58
LintermanMADentonAEDivekarDPZvetkovaIKaneLFerreiraCet alCD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection. Elife (2014) 3:e03180.10.7554/eLife.03180
59
LintermanMARigbyRJWongRSilvaDWithersDAndersonGet alRoquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS. Immunity (2009) 30:228–41.10.1016/j.immuni.2008.12.015
60
RasheedAURahnHPSallustoFLippMMullerG. Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur J Immunol (2006) 36:1892–903.10.1002/eji.200636136
61
BreitfeldDOhlLKremmerEEllwartJSallustoFLippMet alFollicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med (2000) 192:1545–52.10.1084/jem.192.11.1545
62
AnselKMMcHeyzer-WilliamsLJNgoVNMcHeyzer-WilliamsMGCysterJG. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J Exp Med (1999) 190:1123–34.10.1084/jem.190.8.1123
63
ArnoldCNCampbellDJLippMButcherEC. The germinal center response is impaired in the absence of T cell-expressed CXCR5. Eur J Immunol (2007) 37:100–9.10.1002/eji.200636486
64
HardtkeSOhlLForsterR. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood (2005) 106:1924–31.10.1182/blood-2004-11-4494
65
HaynesNMAllenCDLesleyRAnselKMKilleenNCysterJG. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol (2007) 179:5099–108.10.4049/jimmunol.179.8.5099
66
VaethMMullerGStaussDDietzLKlein-HesslingSSerflingEet alFollicular regulatory T cells control humoral autoimmunity via NFAT2-regulated CXCR5 expression. J Exp Med (2014) 211:545–61.10.1084/jem.20130604
67
MartinezGJHuJKPereiraRMCramptonJSTogherSBildNet alCutting edge: NFAT transcription factors promote the generation of follicular helper T cells in response to acute viral infection. J Immunol (2016) 196:2015–9.10.4049/jimmunol.1501841
68
AkibaHTakedaKKojimaYUsuiYHaradaNYamazakiTet alThe role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J Immunol (2005) 175:2340–8.10.4049/jimmunol.175.4.2340
69
BossallerLBurgerJDraegerRGrimbacherBKnothRPlebaniAet alICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J Immunol (2006) 177:4927–32.10.4049/jimmunol.177.7.4927
70
ChoiYSKageyamaREtoDEscobarTCJohnstonRJMonticelliLet alICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity (2011) 34:932–46.10.1016/j.immuni.2011.03.023
71
GigouxMShangJPakYXuMChoeJMakTWet alInducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase. Proc Natl Acad Sci U S A (2009) 106:20371–6.10.1073/pnas.0911573106
72
RolfJBellSEKovesdiDJanasMLSoondDRWebbLMet alPhosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J Immunol (2010) 185:4042–52.10.4049/jimmunol.1001730
73
PedrosCZhangYHuJKChoiYSCanonigo-BalancioAJYatesJRIIIet alA TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1. Nat Immunol (2016) 17:825–33.10.1038/ni.3463
74
BauquetATJinHPatersonAMMitsdoerfferMHoICSharpeAHet alThe costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol (2009) 10:167–75.10.1038/ni.1690
75
ZengHCohenSGuyCShresthaSNealeGBrownSAet almTORC1 and mTORC2 kinase signaling and glucose metabolism drive follicular helper T cell differentiation. Immunity (2016) 45:540–54.10.1016/j.immuni.2016.08.017
76
StoneELPepperMKatayamaCDKerdilesYMLaiCYEmslieEet alICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation. Immunity (2015) 42:239–51.10.1016/j.immuni.2015.01.017
77
CrottySKershENCannonsJSchwartzbergPLAhmedR. SAP is required for generating long-term humoral immunity. Nature (2003) 421:282–7.10.1038/nature01318
78
CannonsJLQiHLuKTDuttaMGomez-RodriguezJChengJet alOptimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity (2010) 32:253–65.10.1016/j.immuni.2010.01.010
79
QiHCannonsJLKlauschenFSchwartzbergPLGermainRN. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature (2008) 455:764–9.10.1038/nature07345
80
CannonsJLYuLJJankovicDCrottySHoraiRKirbyMet alSAP regulates T cell-mediated help for humoral immunity by a mechanism distinct from cytokine regulation. J Exp Med (2006) 203:1551–65.10.1084/jem.20052097
81
RogersPRSongJGramagliaIKilleenNCroftM. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity (2001) 15:445–55.10.1016/S1074-7613(01)00191-1
82
CroftMSoTDuanWSorooshP. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev (2009) 229:173–91.10.1111/j.1600-065X.2009.00766.x
83
CroftM. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol (2010) 28:57–78.10.1146/annurev-immunol-030409-101243
84
BoettlerTMoeckelFChengYHeegMSalek-ArdakaniSCrottySet alOX40 facilitates control of a persistent virus infection. PLoS Pathog (2012) 8:e1002913.10.1371/journal.ppat.1002913
85
ZanderRAObeng-AdjeiNGuthmillerJJKuluDILiJOngoibaAet alPD-1 Co-inhibitory and OX40 Co-stimulatory crosstalk regulates helper T cell differentiation and anti-plasmodium humoral immunity. Cell Host Microbe (2015) 17:628–41.10.1016/j.chom.2015.03.007
86
MarriottCLMackleyECFerreiraCVeldhoenMYagitaHWithersDR. OX40 controls effector CD4+ T-cell expansion, not follicular T helper cell generation in acute Listeria infection. Eur J Immunol (2014) 44:2437–47.10.1002/eji.201344211
87
BoettlerTChoiYSSalek-ArdakaniSChengYMoeckelFCroftMet alExogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular Th cell differentiation and diverts CD4 T cells into the effector lineage by upregulating Blimp-1. J Immunol (2013) 191:5026–35.10.4049/jimmunol.1300013
88
ByunMMaCSAkcayAPedergnanaVPalendiraUMyoungJet alInherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med (2013) 210:1743–59.10.1084/jem.20130592
89
JacqueminCSchmittNContin-BordesCLiuYNarayananPSeneschalJet alOX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response. Immunity (2015) 42:1159–70.10.1016/j.immuni.2015.05.012
90
MaJFengDWeiYTianJTangXRuiKet alBlockade of glucocorticoid-induced tumor necrosis factor-receptor-related protein signaling ameliorates murine collagen-induced arthritis by modulating follicular helper T cells. Am J Pathol (2016) 186:1559–67.10.1016/j.ajpath.2016.02.010
91
ClouthierDLZhouACWortzmanMELuftOLevyGAWattsTH. GITR intrinsically sustains early type 1 and late follicular helper CD4 T cell accumulation to control a chronic viral infection. PLoS Pathog (2015) 11:e1004517.10.1371/journal.ppat.1004517
92
BennettFLuxenbergDLingVWangIMMarquetteKLoweDet alProgram death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol (2003) 170:711–8.10.4049/jimmunol.170.2.711
93
SagePTFranciscoLMCarmanCVSharpeAH. The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. Nat Immunol (2012) 14:152–61.10.1038/ni.2496
94
WingJBIseWKurosakiTSakaguchiS. Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4. Immunity (2014) 41:1013–25.10.1016/j.immuni.2014.12.006
95
HoffHKolarPAmbachARadbruchABrunner-WeinzierlMC. CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch. Mol Immunol (2010) 47:1875–81.10.1016/j.molimm.2010.03.017
96
XiaoNEtoDEllyCPengGCrottySLiuYC. The E3 ubiquitin ligase Itch is required for the differentiation of follicular helper T cells. Nat Immunol (2014) 15:657–66.10.1038/ni.2912
97
RayJPMarshallHDLaidlawBJStaronMMKaechSMCraftJ. Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity (2014) 40:367–77.10.1016/j.immuni.2014.02.005
98
EddahriFDenanglaireSBureauFSpolskiRLeonardWJLeoOet alInterleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. Blood (2009) 113:2426–33.10.1182/blood-2008-04-154682
99
WuSYangTPanFXiaGHuYLiuLet alIncreased frequency of circulating follicular helper T cells in patients with ankylosing spondylitis. Mod Rheumatol (2014) 25:110–5.10.3109/14397595.2014.902149
100
JohnstonRJPoholekACDiToroDYusufIEtoDBarnettBet alBcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science (2009) 325:1006–10.10.1126/science.1175870
101
YuDRaoSTsaiLMLeeSKHeYSutcliffeELet alThe transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity (2009) 31:457–68.10.1016/j.immuni.2009.07.002
102
PoholekACHansenKHernandezSGEtoDChandeleAWeinsteinJSet alIn vivo regulation of Bcl6 and T follicular helper cell development. J Immunol (2010) 185:313–26.10.4049/jimmunol.0904023
103
YangJATuboNJGearhartMDBardwellVJJenkinsMK. Cutting edge: Bcl6-interacting corepressor contributes to germinal center T follicular helper cell formation and B cell helper function. J Immunol (2015) 194:5604–8.10.4049/jimmunol.1500201
104
NanceJPBelangerSJohnstonRJTakemoriTCrottyS. Cutting edge: T follicular helper cell differentiation is defective in the absence of Bcl6 BTB repressor domain function. J Immunol (2015) 194:5599–603.10.4049/jimmunol.1500200
105
NanceJPBelangerSJohnstonRJHuJKTakemoriTCrottyS. Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3. Proc Natl Acad Sci U S A (2015) 112:13324–9.10.1073/pnas.1507312112
106
PotCJinHAwasthiALiuSMLaiCYMadanRet alCutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol (2009) 183:797–801.10.4049/jimmunol.0901233
107
KroenkeMAEtoDLocciMChoMDavidsonTHaddadEKet alBcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol (2012) 188:3734–44.10.4049/jimmunol.1103246
108
LiuXChenXZhongBWangAWangXChuFet alTranscription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. Nature (2014) 507:513–8.10.1038/nature12910
109
BolligNBrustleAKellnerKAckermannWAbassERaiferHet alTranscription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation. Proc Natl Acad Sci U S A (2012) 109:8664–9.10.1073/pnas.1205834109
110
MacianF. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol (2005) 5:472–84.10.1038/nri1632
111
RudenskyAYGavinMZhengY. FOXP3 and NFAT: partners in tolerance. Cell (2006) 126:253–6.10.1016/j.cell.2006.07.005
112
SundrudMSRaoA. New twists of T cell fate: control of T cell activation and tolerance by TGF-Î2 and NFAT. Curr Opin Immunol (2007) 19:287–93.10.1016/j.coi.2007.04.014
113
NurievaRIPoddAChenYAlekseevAMYuMQiXet alSTAT5 protein negatively regulates T follicular helper (Tfh) cell generation and function. J Biol Chem (2012) 287:11234–9.10.1074/jbc.M111.324046
114
JohnstonRJChoiYSDiamondJAYangJACrottyS. STAT5 is a potent negative regulator of TFH cell differentiation. J Exp Med (2012) 209:243–50.10.1084/jem.20111174
115
OzakiKSpolskiREttingerRKimHPWangGQiCFet alRegulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol (2004) 173:5361–71.10.4049/jimmunol.173.9.5361
116
KalliesAHawkinsEDBelzGTMetcalfDHommelMCorcoranLMet alTranscriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat Immunol (2006) 7:466–74.10.1038/ni1321
117
MartinsGACimminoLShapiro-ShelefMSzabolcsMHerronAMagnusdottirEet alTranscriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol (2006) 7:457–65.10.1038/ni1320
118
CimminoLMartinsGALiaoJMagnusdottirEGrunigGPerezRKet alBlimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression. J Immunol (2008) 181:2338–47.10.4049/jimmunol.181.4.2338
119
NakayamadaSKannoYTakahashiHJankovicDLuKTJohnsonTAet alEarly Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity (2011) 35:919–31.10.1016/j.immuni.2011.11.012
120
ShawLABelangerSOmilusikKDChoSScott-BrowneJPNanceJPet alId2 reinforces TH1 differentiation and inhibits E2A to repress TFH differentiation. Nat Immunol (2016) 17:834–43.10.1038/ni.3461
121
FengXWangHTakataHDayTJWillenJHuH. Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nat Immunol (2011) 12:544–50.10.1038/ni.2034
122
WangHGengJWenXBiEKossenkovAVWolfAIet alThe transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells. Nat Immunol (2014) 15:667–75.10.1038/ni.2890
123
KerdilesYMBeisnerDRTinocoRDejeanASCastrillonDHDePinhoRAet alFoxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol (2009) 10:176–84.10.1038/ni.1689
124
LeeHYYounSWChoHJKwonYWLeeSWKimSJet alFOXO1 impairs whereas statin protects endothelial function in diabetes through reciprocal regulation of Kruppel-like factor 2. Cardiovasc Res (2012) 97:143–52.10.1093/cvr/cvs283
125
Gubbels BuppMREdwardsBGuoCWeiDChenGWongBet alT cells require Foxo1 to populate the peripheral lymphoid organs. Eur J Immunol (2009) 39:2991–9.10.1002/eji.200939427
126
CarlsonCMEndrizziBTWuJDingXWeinreichMAWalshERet alKruppel-like factor 2 regulates thymocyte and T-cell migration. Nature (2006) 442:299–302.10.1038/nature04882
127
BaiAHuHYeungMChenJ. Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J Immunol (2007) 178:7632–9.10.4049/jimmunol.178.12.7632
128
TakadaKWangXHartGTOdumadeOAWeinreichMAHogquistKAet alKruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells. J Immunol (2010) 186:775–83.10.4049/jimmunol.1000094
129
WuTShinHMMosemanEAJiYHuangBHarlyCet alTCF1 is required for the T follicular helper cell response to viral infection. Cell Rep (2015) 12:2099–110.10.1016/j.celrep.2015.08.049
130
XuLCaoYXieZHuangQBaiQYangXet alThe transcription factor TCF-1 initiates the differentiation of TFH cells during acute viral infection. Nat Immunol (2015) 16:991–9.10.1038/ni.3229
131
ChoiYSGullicksrudJAXingSZengZShanQLiFet alLEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat Immunol (2015) 16:980–90.10.1038/ni.3226
132
MathewRMaoAPChiangAHBertozzi-VillaCBunkerJJScanlonSTet alA negative feedback loop mediated by the Bcl6-cullin 3 complex limits Tfh cell differentiation. J Exp Med (2014) 211:1137–51.10.1084/jem.20132267
133
LintermanMARigbyRJWongRKYuDBrinkRCannonsJLet alFollicular helper T cells are required for systemic autoimmunity. J Exp Med (2009) 206:561–76.10.1084/jem.20081886
134
PratamaARamiscalRRSilvaDGDasSKAthanasopoulosVFitchJet alRoquin-2 shares functions with its paralog Roquin-1 in the repression of mRNAs controlling T follicular helper cells and systemic inflammation. Immunity (2013) 38:669–80.10.1016/j.immuni.2013.01.011
135
VogelKUEdelmannSLJeltschKMBertossiAHegerKHeinzGAet alRoquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation. Immunity (2013) 38:655–68.10.1016/j.immuni.2012.12.004
136
BertossiAAichingerMSansonettiPLechMNeffFPalMet alLoss of Roquin induces early death and immune deregulation but not autoimmunity. J Exp Med (2011) 208:1749–56.10.1084/jem.20110578
137
RamiscalRRParishIALee-YoungRSBabonJJBlagihJPratamaAet alAttenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation. Elife (2015) 4:e08698.10.7554/eLife.08698
138
BaumjohannDKageyamaRClinganJMMorarMMPatelSde KouchkovskyDet alThe microRNA cluster miR-17 approximately 92 promotes TFH cell differentiation and represses subset-inappropriate gene expression. Nat Immunol (2013) 14:840–8.10.1038/ni.2642
139
WuTWielandALeeJHaleJSHanJHXuXet alCutting edge: miR-17-92 is required for both CD4 Th1 and T follicular helper cell responses during viral infection. J Immunol (2015) 195:2515–9.10.4049/jimmunol.1500317
140
HuRKageleDAHuffakerTBRuntschMCAlexanderMLiuJet almiR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation. Immunity (2014) 41:605–19.10.1016/j.immuni.2014.09.015
141
PratamaASrivastavaMWilliamsNJPapaILeeSKDinhXTet alMicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres. Nat Commun (2015) 6:6436.10.1038/ncomms7436
Summary
Keywords
T follicular helper cell, CXCR5, ICOS, B cell lymphoma 6, programed death 1
Citation
Jogdand GM, Mohanty S and Devadas S (2016) Regulators of Tfh Cell Differentiation. Front. Immunol. 7:520. doi: 10.3389/fimmu.2016.00520
Received
24 August 2016
Accepted
08 November 2016
Published
23 November 2016
Volume
7 - 2016
Edited by
Loretta Tuosto, Sapienza University, Italy
Reviewed by
Shahram Salek-Ardakani, University of Florida, USA; Hiroshi Nakajima, Chiba University, Japan
Updates
Copyright
© 2016 Jogdand, Mohanty and Devadas.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Satish Devadas, satdevs@ils.res.in
Specialty section: This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.